Navigation Links
Genaera Corporation Announces Second Quarter Financial Results
Date:8/11/2008

periods in 2007. The decrease in the three-month period ended June 30, 2008 was due principally to decreases in realignment costs, bonus expense, public company expenses and accounting fees. The decrease was partially offset by an increase in stock-based compensation expense. The increase in the six-month period ended June 30, 2008 was due principally to an increase in stock-based compensation expense. This increase was partially offset by decreases in realignment costs, payroll expenses, bonus expense, accounting fees and public company expenses.

The Company's cash, cash equivalents and short-term investment balance was $12.8 million at June 30, 2008.

About Genaera

Genaera Corporation is focused on advancing the science and treatment of metabolic diseases. The Company has significant market opportunities with a first-in-class molecule, trodusquemine (MSI-1436), that has the potential to redefine the treatment paradigm for obesity and type 2 diabetes and is presently in a phase 1 trial in obesity. In addition, Genaera has a value-driven, fully out-licensed partnership with MedImmune, Inc. for a second core program that is presently undergoing phase 2 clinical testing in asthma. Genaera is committed to directing resources to its core program and the aggressive clinical development of its key assets to build stockholder value. For further information, please see our website at http://www.genaera.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. Such statements include, among others, statements regarding the preliminary results, clinical development plans and prospects for Genaera's programs including trodusquemine (MSI-1436) and t
'/>"/>

SOURCE Genaera Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Genaera Elects New Board Member and Announces Executive Appointments
2. Genaera to Present at Biotech 2007 and BIO InvestorForum
3. Genaera Corporation Announces Third Quarter Financial Results
4. Genaera Corporation to Participate in Diabetes and Obesity Panel at RBC Capital Markets Healthcare Conference
5. Genaera Corporation Announces 2007 Financial Results
6. Genaera Corporation Announces First Quarter Financial Results
7. Genaera Corporation to Present at BIO Business Forum
8. Genaera Corporation Elects Paul K. Wotton to Board of Directors
9. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
10. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2009)... Inc. (Nasdaq: ELGX ), developer of minimally ... Dan Lemaitre, former President and CEO of CoreValve, ... December 11, 2009. Endologix now has four ... D. Brown, Chairman of the Board, said, "We ... Endologix Board of Directors. He has a ...
(Date:12/10/2009)... BioSciences Inc. (NYSE Amex: YMI ; TSX: ... identifies and advances a diverse portfolio of promising ... provided an update on the proposed transaction which ... into YM, details of which were announced on ... Cytopia has unanimously recommended that its shareholders vote ...
(Date:12/10/2009)... BEIJING, Dec. 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, ... "Company") a growing developer and,producer of prescription ... in the People,s Republic of China ("PRC"), ... Fang, a controlled operating entity of Lotus,appointed ... of the Company,s,Over-the-Counter Drug division ("OTC Division"). ...
(Date:12/10/2009)... Produces First Candidates Which Selectively Target HER2 ... 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE ... of a collaborative program between YM and ... Canada,s Biotechnology Research Institute (NRC-BRI). Utilizing YM,s ... generate novel antibodies that target cell surface ...
Breaking Biology Technology:Endologix Appoints Dan Lemaitre to its Board of Directors 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 2Lotus Pharmaceuticals, Inc. Appoints OTC Division Head 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5
... change as a result of the Sarbanes-Oxley Act ... and companies to continually evaluate their financial controls ... to the technology requirements and information technology (IT) ... technology; however, it is difficult to envision compliance ...
... has an ancient and proud history of interstate sports ... Sometimes, like this past New Years Day, the rivalry ... Wolverines and marijuana have in common? They both get ... be fomenting another interstate rivalry. This one is of ...
... will support American Musical Supplys (AMS) expansion plans ... solutions. AMS , a supplier of musical ... next year and develop business-to-business sales channels using ... , ,AMS was driven to establish a ...
Other Biology Technology:Technology Implications of Sarbanes-Oxley 2Technology Implications of Sarbanes-Oxley 3For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund 2For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund 3For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund 4
(Date:12/13/2009)... Haven, Conn.A team led by Yale University researchers ... whole blood for the first time. Their findings, ... publication of Nature Nanotechnology , could dramatically ... cancer and other diseases. , The ... of Engineering & Applied Science, and Tarek Fahmy, ...
(Date:12/11/2009)... Malus orientalis species of wild apples that could be ... Middle East and Central Asia. A new study comparing ... varieties from Georgia and Armenia with previously collected varieties ... and establishes a core collection that will make ... research communities. , To identify and record the genetic ...
(Date:12/11/2009)... an associate professor of anthropology at the University of ... Kenya to understand how violence shapes the health of ... of her and her colleagues, research," Documenting the health ... northern Kenya: A conceptual framework," is currently published in ... , in collaboration with the British medical journal the ...
Breaking Biology News(10 mins):Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Understanding apples' ancestors 2UA-led study grapples with health effects of low-intensity warfare 2Yoga Can Ease Lower Back Pain 56417 1Yoga Can Ease Lower Back Pain 56417 2Yoga Can Ease Lower Back Pain 56417 3Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 1Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 2Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 3Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 4Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 5Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 6Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 7Reportlinker Adds Gastrointestinal Endoscopy Devices Report 56412 8K State Veterinarian Says Dog Owners Can Make Themselves Their Pets Healthier With Physical Activity Based on Dogs Specific Needs Interests 56409 1K State Veterinarian Says Dog Owners Can Make Themselves Their Pets Healthier With Physical Activity Based on Dogs Specific Needs Interests 56409 2K State Veterinarian Says Dog Owners Can Make Themselves Their Pets Healthier With Physical Activity Based on Dogs Specific Needs Interests 56409 3K State Veterinarian Says Dog Owners Can Make Themselves Their Pets Healthier With Physical Activity Based on Dogs Specific Needs Interests 56409 4
... advanced image, processing technology to the difficult challenge of rapidly ... ... 1 Aware, Inc. (Nasdaq:,AWRE), a global provider of imaging ... of software,development kits used to perform rapid autocapture and compliance ...
... living longer despite cellular defects, a discovery that is ... how doctors could one day limit or reverse genetic ... University of Colorado at Boulder study. , In the ... metabolic state of genetically engineered lab worms called C. ...
... p.m. to 7:30 p.m. , The New York Academy ... 40th Floor, New York, NY 10007 , The Malaria ... Public Health and The New York Academy of Sciences ... half-day symposium to highlight the latest research developments in ...
Other Biology News:Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture 2Aware, Inc. Introduces Biometrics Software for Tenprint Autocapture 3CU-Boulder worm study sheds light on human aging, inherited diseases 2CU-Boulder worm study sheds light on human aging, inherited diseases 3Progress Against Malaria: Developments on the Horizon 2
B2-Microgloulin...
Rabbit Anti-Ferret Whole Serum Antibody, Unconjugated...
... priced, full ring small animal imaging PET ... microPET R4 low retail price, it outperfoms ... count rate performance, energy resolution, timing resolution, ... small animal PET (Positron Emission Tomography) imaging ...
... product has been developed to significantly increase ... proteins. Stability is increased at room ... centigrade. This product is subjected to ... or azide. This formulation insures consistently ...
Biology Products: